Your email has been successfully added to our mailing list.

×
0.0615384615384616 0.0615384615384616 0.0615384615384616 -0.0076923076923077 -0.0076923076923077 -0.0076923076923077 0.0346153846153846 0.0076923076923077
Stock impact report

Alterity Therapeutics appoints Abby Macnish Niven as CFO [Seeking Alpha]

Alterity Therapeutics Limited - American Depositary Shares (ATHE) 
Company Research Source: Seeking Alpha
Ms Macnish Niven will replace Mr Phillip Hains, who supported Alterity as CFO from December 2023. Mr Hains continues as Company Secretary. More on Alterity Therapeutics Seeking Alpha's Quant Rating on Alterity Therapeutics Historical earnings data for Alterity Therapeutics Financial information for Alterity Therapeutics Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
ATHE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ATHE alerts
Opt-in for
ATHE alerts

from News Quantified
Opt-in for
ATHE alerts

from News Quantified